Business Development & Out-licensing


After the divestment of Combino Pharm hospital division in Spain and Portugal in April 2015, Medichem took charge of Combino Pharm’s pharmaceutical developments and thus incorporated a broad portfolio of oral and injectable finished dosage forms which are available for outlicensing purposes. Besides, the Team of Business Development constantly receive additions to the portfolio with new products under development and under consideration. The interaction with our partners is key.


Over the last years we have changed our approach with regards to the development capabilitites. Now, Medichem offers both dossiers based on internal developments and also dossiers coming from codevelopments.

Flexibility in the business model, by:

  • License and supply
  • Distribution
  • Direct import opportunities
  • Availability of Marketing Authorizations ready to be transferred
  • Availability of CPP (Certificate of Pharmaceutical Product)
  • Industrial property experts worldwide
  • Regulatory Affairs with experience in more than 70 countries.
  • Own production plant, strategically located in Malta.
  • Patent launch opportunity Expiry + 1 day
  • Agility and support throughout the process
© Copyright - Medichem